Specificity of Cell-Mediated Immunoreactivity in Melanoma and Comments on the Nature of Serum Blocking Factors

  • W. J. Halliday


Malignant melanoma is, from the immunological viewpoint, one of the most extensively studied of all cancers. It is sometimes stated that the reason lies in the tendency of melanoma to undergo spontaneous regression. The assumption is made that regression necessarily has an immunological basis and furthermore that host immunity should thus be more readily demonstrable in melanoma than in other cancers. These concepts are simplistic: tumor regression might have many different mechanisms, and identifiable criteria of immunoreactivity in melanoma patients are typical of many cancers. Nevertheless, there are good practical reasons for choosing to study melanoma as a model of tumor immunity. In Queensland, melanoma is not uncommon; the incidence is the highest in the world at over 30 per 100,000, and clinical material is thus relatively abundant. The visibility of the cutaneous tumor, and intensive health education, combine to ensure that many melanomas are detected at an early stage, identified by experienced clinicians and histopathologists, and removed successfully by adequate surgery (Smith, 1979).


Melanoma Patient Soluble Antigen Tumor Extract Melanoma Antigen Adherence Inhibition 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Avis, F., Avis, I., Newsome, J. F., and Haughton, G., 1976, Antigenic cross-reactivity between adenocarcinoma of the breast and fibrocystic disease of the breast, J. Natl. Cancer Inst. 56: 17.PubMedGoogle Scholar
  2. Baldwin, R. W., Price, M. R., and Robins, R. A., 1972, Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexes, Nature (London) New Biol. 238 :185. Google Scholar
  3. Burger, D. R., Vandenbark, A. A., Finke, P., Malley, A., Frikke, M., Black, J., Acott, K., Begley, D., and Vetto, R. M., 1977, Assessment of reactivity to tumor extracts by leukocyte adherence inhibition and dermal testing, J. Natl. Cancer Inst. 59:317.Google Scholar
  4. Creemers, P., 1977, The role of leukocyte subpopulations in the indirect leukocyte adherence inhibition assay in the mammary tumor virus system, Eur. J. Immunol. 7:48.PubMedCrossRefGoogle Scholar
  5. Dunn, I. S., and Halliday, W. J., 1980, Interactions between T and B lymphocytes and macrophages in the production of leukocyte adherence inhibition factor, Cell. Immunol. 52:48.PubMedCrossRefGoogle Scholar
  6. Fidler, I. J., and Kripke, M. L., 1980, Tumor cell antigenicity, host immunity and cancer metastasis, Cancer Immunol. Immunother. 7:201.Google Scholar
  7. Fujisawa, T., Waldman, S. R., and Yonemoto, R. H., 1978, Transfer factor in vitro abrogation of blocking factors and amplification of immunoreactivity directed to soluble tumor-associated antigens in the leukocyte adherence inhibition assay, Cancer Immunol. Immunother. 4:77.CrossRefGoogle Scholar
  8. Gardner, M. A. H., Maluish, A. E., Halliday, W. J., and Clunie, G. J. A., 1975, Immunodiagnosis of a metastasis in a patient with a history of double malignant disease, Med. J. Aust. 1:446.PubMedGoogle Scholar
  9. Goldrosen, M. H., and Howell, J. H., 1979, International workshop on leukocyte adherence inhibition, Cancer Res. 39:551.Google Scholar
  10. Goldrosen, M. H., Russo, A. J., Howell, J. H., Leveson, S. H., and Holyoke, E. D., 1979, Cellular and humoral factors involved in the mechanism of the micro-leukocyte adherence inhibition reaction, Cancer Res. 39:587.PubMedGoogle Scholar
  11. Greene, M. I., Dorf, M. E., Pierres, M., and Benacerraf, B., 1977, Reduction of syngeneic tumor growth by an anti-I-J alloantiserum, Proc. Natl. Acad. Sci. U.S.A. 74:5118.PubMedCrossRefGoogle Scholar
  12. Grosser, N., and Thomson, D. M. P., 1975, Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes, Cancer Res. 35:2571.PubMedGoogle Scholar
  13. Halliday, W. J., 1979, Historical background and aspects of the mechanism of leukocyte adherence inhibition, Cancer Res. 39:558.PubMedGoogle Scholar
  14. Halliday, W. J., and Miller, S., 1972, Leukocyte adherence inhibition: A simple test for cell-mediated tumour immunity and serum blocking factors, Int. J. Cancer 9:477.PubMedCrossRefGoogle Scholar
  15. Halliday, W. J., Halliday, J. W., Campbell, C. B., Maluish, A. E., and Powell, L. W., 1974a, Specific immunodiagnosis of hepatocellular carcinoma by leucocyte adherence inhibition, Br. Med. J. 2:349.CrossRefGoogle Scholar
  16. Halliday, W. J., Maluish, A. E., and Isbister, W. H., 19746, Detection of anti-tumour cell mediated immunity and serum-blocking factors in cancer patients by the leucocyte adherence inhibition test, Br. J. Cancer 29:31.Google Scholar
  17. Halliday, W. J., Maluish, A. E., and Miller, S., 1974c, Blocking and unblocking of cell-mediated anti-tumor immunity in mice, as detected by the leukocyte adherence inhibition test, Cell. Immunol. 10:467.CrossRefGoogle Scholar
  18. Halliday, W. J., Maluish, A. E., Little, J. H., and Davis, N. C., 1975, Leukocyte adherence inhibition and specific immunoreactivity in malignant melanoma, Int. J. Cancer 16:645.PubMedCrossRefGoogle Scholar
  19. Halliday, W. J., Koppi, T. A., Kahn, J., and Davis, N. C., 1980, Leukocyte adherence inhibition: Tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer and colorectal cancer, J. Natl. Cancer Inst. 65:327.PubMedGoogle Scholar
  20. Hellström, I., and Hellström, K. E., 1973, Some recent studies on cellular immunity to human melanomas, Fed. Proc. Fed. Am. Soc. Exp. Biol. 32:156.Google Scholar
  21. Hellström, I., Hellström, K. E., Pierce, G. E., and Yang, J. P. S., 1968, Cellular and humoral immunity to different types of human neoplasms, Nature (London) 220:1352.CrossRefGoogle Scholar
  22. Hellström, I., Hellström, K. E., Evans, C. A., Heppner, G. H., Pierce, G. E., and Yang, J. P. S., 1969, Serum-mediated protection of neoplastic cells from inhibition by lymphocytes immune to their tumor-specific antigens, Proc. Natl. Acad. Sci. U.S.A. 62:362.PubMedCrossRefGoogle Scholar
  23. Hellström, I., Hellström, K. E., Bill, A. H., Pierce, G. E., and Yang, J. P. S., 1970, Studies on cellular immunity to human neuroblastoma cells, Int. J. Cancer 6:172.PubMedCrossRefGoogle Scholar
  24. Hellström, I., Warner, G. A., Hellström, K. E., and Sjögren, H. 0., 1973, Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma, Int. J. Cancer 11:280.PubMedCrossRefGoogle Scholar
  25. Hellström, I., Hellström, K. E., Van Belle, G., and Warner, G. A., 1977, Leukocyte-mediated reactivity to human tumors as detected by the leukocyte adherence inhibition test. I. Demonstration of tumor type-specific reactions, Am. J. Clin. Pathol. 68:706.PubMedGoogle Scholar
  26. Hellström, K. E., Hellström, I., and Nepom, J. T., 1977, Specific blocking factors—are they important?, Biochim. Biophys. Acta 473:121.PubMedGoogle Scholar
  27. Herberman, R. B., and Holden, H. T., 1979, Natural killer cells as antitumor effector cells, J. Natl. Cancer Inst. 62:441.PubMedGoogle Scholar
  28. Holân, V., Hasek, M., Bubeník, J., and Chutnâ, J., 1974, Antigen-mediated macrophage adherence inhibition, Cell. Immunol. 13:107.PubMedCrossRefGoogle Scholar
  29. Holt, P. G., Roberts, L. M., Fimmel, P. J., and Keast, D., 1975, The LAI microtest: A rapid and sensitive procedure for the demonstration of cell-mediated immunity in vitro, J. Immunol. Methods 8:277.PubMedCrossRefGoogle Scholar
  30. Koppi, T. A., and Halliday, W. J., 1981, Regulation of cell-mediated immunologic reactivity to Moloney murine sarcoma virus-induced tumors, J. Nat. Cancer Inst.66:1089.Google Scholar
  31. Koppi, T. A., Maluish, A. E., and Halliday, W. J., 1979, The cellular mechanism of leukocyte adherence inhibition, J. Immunol. 123:2255.PubMedGoogle Scholar
  32. Leveson, S. H., Howell, J. H., Paolini, N. S., Tan, M. H., Holyoke, E. D., and Goldrosen, M. H., 1979, Correlations between the leukocyte adherence inhibition microassay and in vivo tests of transplantation resistance, Cancer Res. 39:582.PubMedGoogle Scholar
  33. Maluish, A. E., and Halliday, W. J., 1979, Hemocytometer leukocyte adherence inhibition technique, Cancer Res. 39:625.PubMedGoogle Scholar
  34. Marti, J. H., Grosser, N., and Thomson, D. M. P., 1976, Tube leukocyte adherence inhibition assay for the detection of anti-tumour immunity. II. Monocyte reacts with tumour antigens via cytophilic anti-tumour antibody, Int. J. Cancer 18:48.PubMedCrossRefGoogle Scholar
  35. McCoy, J. L., Maluish, A. E., Halliday, W. J., and Herberman, R. B., 1980, Leukocyte migration inhibitory factor and leukocyte adherence inhibition assays, in: Manual of Clinical Immunology, 2nd ed. (N. R. Rose and H. Friedman, eds.), pp. 252–260, American Society for Microbiology, Washington.Google Scholar
  36. Mortensen, R. F., 1979, Detection of cellular immunity to murine sarcoma virus-induced tumours by leukocyte adherence inhibition, J. Natl. Cancer Inst. 62:157.PubMedGoogle Scholar
  37. Mortensen, R. F., and Elson, L. M., 1980, Leukocyte adherence inhibition response to murine sarcoma virus-induced tumors. I. Cell requirements, specificity, lack of H-2 restriction, and role of antibody, J. Immunol. 124:2316.PubMedGoogle Scholar
  38. Nepom, J. T., Hellström, I., and Hellström, K. E., 1976, Purification and partial characterization of a tumor-specific blocking factor from sera of mice with growing chemically induced sarcomas, J. Immunol. 117:1846.PubMedGoogle Scholar
  39. Noonan, F. P., and Halliday, W. J., 1980, Genetic restriction of the serum factor mediating tolerance in trinitrochlorobenzene hypersensitivity, Cell. Immunol. 50:41.PubMedCrossRefGoogle Scholar
  40. Noonan, F. P., Halliday, W. J., Wall, D. R., and Clunie, G. J. A., 1977, Cell-mediated immunity and serum blocking factors in cancer patients during chemotherapy and immunotherapy, Cancer Res. 37:2473.PubMedGoogle Scholar
  41. O’Connor, R., MacFarlane, J. K., Murray, D., and Thomson, D. M. P., 1978, A study of false positive and negative responses in the tube leucocyte adherence inhibition (tube LAI) assay, Br. J. Cancer 38:674.PubMedCrossRefGoogle Scholar
  42. Powell, A. E., Sloss, A. M., Smith, R. N., Makley, J. T., and Hubay, C. A., 1975, Specific responsiveness of leukocytes to soluble extracts of human tumors, Int. J. Cancer 16:905.PubMedCrossRefGoogle Scholar
  43. Powell, A. E., Sloss, A. M., and Smith, R. N., 1978, Leucocyte adherence inhibition: A specific assay of cell-mediated immunity dependent on lymphokine-mediated collaboration between T-lymphocytes, J. Immunol. 120:1957.PubMedGoogle Scholar
  44. Russo, A. J., Douglass, H. O., Leveson, S. H., Howell, J. H., Holyoke, E. D., Harvey, S. R., Chu, T. M., and Goldrosen, M. H., 1978, Evaluation of the microleukocyte adherence inhibition assay as an immunodiagnostic test for pancreatic cancer, Cancer Res. 38:2023.PubMedGoogle Scholar
  45. Sjögren, H. O., Hellström, I., Bansal, S. C., and Hellström, K. E., 1971, Suggestive evidence that the “blocking antibodies” of tumor-bearing individuals may be antigen-antibody complexes, Proc. Natl. Acad. Sci. U.S.A. 68:1372.PubMedCrossRefGoogle Scholar
  46. Smith, T., 1979, The Queensland Melanoma Project—an exercise in health education, Br. Med. J. 1:253.PubMedCrossRefGoogle Scholar
  47. Vandenbark, A. A., Greene, M. H., Burger, D. R., Vetto, R. M., and Reimer, R. R., 1979, Immune response to melanoma extracts in three melanoma-prone families, J. Natl. Cancer Inst. 63:1147.PubMedGoogle Scholar
  48. Winter, M., Nelson, D. S., and Milton, G. W., 1980, Leucocyte adherence inhibition test for the detection of cell-mediated immunity to malignant melanoma, Aust. N. Z. J. Med. 10:405.PubMedCrossRefGoogle Scholar
  49. Yamauchi, K., Fujimoto, S., and Tada, T., 1979, Differential activation of cytotoxic and suppressor T cells against syngeneic tumors in the mouse, J. Immunol. 123:1653.PubMedGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • W. J. Halliday
    • 1
  1. 1.Department of MicrobiologyUniversity of QueenslandBrisbaneAustralia

Personalised recommendations